Evidence map›Paper›PMID 32927329›Full record

ArticleEpilepsy research2020

Management of West syndrome during COVID-19 pandemic: A viewpoint from South Asian West Syndrome Research Group.

Jitendra Kumar Sahu, Priyanka Madaan, Prem Chand, Amit Kumar, Kyaw Linn, Mimi Lhamu Mynak, Prakash Poudel, Jithangi Wanigasinghe

Open access · greenAbstract read
In one paragraph

Article in Epilepsy research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Observational
  2. Review
  3. Observational
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 5 countries.

Jitendra Kumar SahuPediatric Neurology Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India. Electronic address: jsh2003@gmail.com.
Priyanka MadaanPediatric Neurology Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Prem ChandAga Khan University, Karachi, Pakistan.
Amit KumarDepartment of Neurology, All India Institute of Medical Sciences, New Delhi, India.
Kyaw LinnPediatric Neurology Unit, Yangon Children Hospital, Myanmar.
Mimi Lhamu MynakDepartment of Pediatrics, Jigme Dorji Wangchuck National Referral Hospital, Thimphu, Bhutan.
Prakash PoudelDepartment of Pediatrics, B.P. Koirala Institute of Health Sciences, Dharan, Nepal.
Jithangi WanigasingheDepartment of Paediatrics, University of Colombo, Sri Lanka.
Post Graduate Institute of Medical Education and Research · INAga Khan University · PKAll India Institute of Medical Sciences · INB.P. Koirala Institute of Health Sciences · NPUniversity of Colombo · LKYangon Children's Hospital · MM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the wake of the pandemic COVID-19 and nationwide lockdowns gripping many countries globally, the national healthcare systems are either overwhelmed or preparing to combat this pandemic. Despite all the containment measures in place, experts opine that this novel coronavirus is here to stay as a pandemic or an endemic. Hence, it is apt to be prepared for the confrontation and its aftermath. From protecting the vulnerable individuals to providing quality care for all health conditions and maintaining essential drug supplies, it is going to be a grueling voyage. Preparedness to sustain optimal care for each health condition is a must. With a higher risk for severe COVID-19 disease in infants, need of high-dose hormonal therapy with a concern of consequent severe disease, presence of comorbidities, and a need for frequent investigations and follow-up; children with West syndrome constitute a distinctive group with special concerns. In this viewpoint, we discuss the important issues and concerns related to the management of West syndrome during COVID-19 pandemic in the South Asian context and provide potential solutions to these concerns based on the current evidence, adeptness, and consensus. Some plausible solutions include the continuation of containment and mitigation measures for COVID-19, therapeutic decision- making for West syndrome based on risk stratification, and tele-epileptology.

Indexed as

TelemedicineAdrenal Cortex HormonesAdrenocorticotropic HormoneAnticonvulsantsAntiviral AgentsBetacoronavirusClinical Decision-MakingCoronavirus InfectionsCOVID-19Delivery of Health CareDrug InteractionsHumansInfantPandemicsPneumonia, ViralSARS-CoV-2Adrenal Cortex HormonesAdrenocorticotropic HormoneAnticonvulsantsAntiviral AgentsVigabatrinCOVID-19Epileptic spasmsInfantile spasmsInfants

Identifiers

PMID32927329
PMCPMC7456842
OpenAlexW3081700741

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.